Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers.
Adze Biotechnology has raised $6.2M in total funding. The most recent round was Series A. The last funding was announced in March 2023.
Adze Biotechnology is headquartered in Coral Gables, United States.
Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers.
Adze Biotechnology is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adze Biotechnology — Funding & Investors." VCBacked, March 14, 2023, https://www.vcbacked.co/company/adze-biotechnology. Accessed August 14, 2026.
VCBacked. (2023). Adze Biotechnology — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/adze-biotechnology
{{cite web |title=Adze Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/adze-biotechnology |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated